Leukemia Market Research Reports
To refine your search by industry, market, geographic region, country or price, use Advanced Search or contact Client Services for assistance.
-
August 1, 2016$4,950.00
-
August 1, 2021$2,500.00
-
October 31, 2022$2,500.00
-
November 30, 2016$2,000.00
-
May 15, 2022$2,500.00
-
April 29, 2022$2,000.00
-
November 18, 2019$2,000.00
-
August 10, 2016$2,000.00
-
March 31, 2017$2,000.00
-
May 31, 2022$2,500.00
-
April 1, 2019$6,250.00
-
October 25, 2018$2,500.00
-
February 28, 2017$2,500.00
-
March 15, 2016$2,000.00
-
February 1, 2016$4,950.00
-
August 1, 2016$4,950.00
-
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H2, 2018October 25, 2018$2,500.00
-
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2020January 15, 2020$2,500.00
-
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017February 28, 2017$2,500.00
-
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017February 9, 2017$2,500.00
-
January 28, 2023$2,500.00
-
December 29, 2017$2,500.00
-
December 28, 2016$2,500.00
-
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021January 8, 2022$2,500.00
-
October 25, 2018$2,500.00